drugset / Trial / NCT03740386

Phentolamine Mesylate as a Reversal of Local Anesthesics

NCT03740386

Completed 90 enrolled León Formación
RandomizedCrossoverDouble-blindTreatment

Summary

Oraverse © (Phentolamine mesylate) is a product designed to reverse the effect of local anesthetics used in dentistry. Its main objective is to reduce the postoperative period during which the patient suffers from the lack of sensitivity in the perioral soft tissues, it is an obvious discomfort, a difficulty to speak or eat, and sometimes a risk of self-injury in the lips and / or tongue . The product was approved by the FDA in 2008 although the introduction in Spain has not occurred until December 2015. There are numerous studies that support its use, its effectiveness and safety, although none of the Spanish population, who have not yet had the opportunity to experience it.

Timeline

Start
2016-01-01
Primary completion
2018-11-09
Completion
2018-11-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Phentolamine Small molecule 0.235 mg/ml

Indications

No indication recorded.